Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-03 Sale |
2022-08-05 4:12 pm |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
9,232 | $9.3069 | $85,921 | 248,015 (Direct) |
View |
| 2022-07-05 Sale |
2022-07-07 4:23 pm |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
9,232 | $8.3683 | $77,256 | 395,480 (Direct) |
View |
| 2022-06-16 Sale |
2022-06-21 6:50 pm |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
67,927 | $6.8299 | $463,935 | 607,580 (Direct) |
View |
| 2022-06-13 Sale |
2022-06-15 6:39 pm |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
26,381 | $6.0823 | $160,457 | 644,324 (Direct) |
View |
| 2022-06-08 Sale |
2022-06-10 6:34 pm |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
27,306 | $6.441 | $175,878 | 507,463 (Direct) |
View |
| 2022-06-03 Sale |
2022-06-07 7:03 pm |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
47,287 | $6.2593 | $295,985 | 797,815 (Direct) |
View |
| 2022-05-18 Purchase |
2022-05-20 4:38 pm |
Edgewise Therapeutics Inc. | EWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director 10% Owner |
138,000 | $7.21 | $994,980 | 13,817,055 (Indirect) |
View |
| 2022-05-18 Purchase |
2022-05-20 4:32 pm |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
138,000 | $7.21 | $994,980 | 13,817,055 (Indirect) |
View |
| 2022-05-16 Sale |
2022-05-18 5:15 pm |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
10,800 | $7.4209 | $80,146 | 3,000 (Direct) |
View |
| 2021-11-15 Sale |
2021-11-17 6:05 pm |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
479 | $19.11 | $9,155 | 0 (Direct) |
View |
| 2021-11-09 Sale |
2021-11-12 5:24 pm |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
69,740 | $19.91 | $1,388,788 | 479 (Direct) |
View |
| 2021-11-04 Sale |
2021-11-08 7:11 pm |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
29,451 | $19.82 | $583,823 | 70,219 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 7:00 pm |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
44,172 | $17.88 | $789,909 | 99,670 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 7:48 pm |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
7,182 | $18.17 | $130,483 | 143,842 (Direct) |
View |
| 2021-10-11 Sale |
2021-10-13 6:51 pm |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
1,270 | $18.02 | $22,885 | 151,024 (Direct) |
View |
| 2021-10-06 Sale |
2021-10-08 6:00 pm |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
21,028 | $18.39 | $386,743 | 152,294 (Direct) |
View |
| 2021-10-01 Sale |
2021-10-05 6:33 pm |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
5,778 | $18.24 | $105,409 | 173,322 (Direct) |
View |
| 2021-09-28 Sale |
2021-09-30 7:16 pm |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
26,454 | $17.1 | $452,483 | 179,100 (Direct) |
View |
| 2021-09-23 Sale |
2021-09-27 7:32 pm |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
58,546 | $18.3 | $1,071,422 | 205,554 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-08-08 Option Award |
2022-08-10 5:41 pm |
N/A 2032-08-08 |
Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO |
240,000 | $0 | 240,000 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-10 5:41 pm |
N/A 2032-08-08 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
550,000 | $0 | 550,000 (Direct) |
View |
| 2022-08-03 Exercise |
2022-08-05 4:12 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
9,232 | $0 | 248,015 (Direct) |
View |
| 2022-08-03 Exercise |
2022-08-05 4:12 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
4,730 | $1.93 | 248,015 (Direct) |
View |
| 2022-08-03 Exercise |
2022-08-05 4:12 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
4,502 | $0.71 | 248,015 (Direct) |
View |
| 2022-07-05 Exercise |
2022-07-07 4:23 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
9,232 | $0 | 395,480 (Direct) |
View |
| 2022-07-05 Exercise |
2022-07-07 4:23 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
4,730 | $1.93 | 395,480 (Direct) |
View |
| 2022-07-05 Exercise |
2022-07-07 4:23 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
4,502 | $0.71 | 395,480 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 7:17 pm |
2023-06-08 2032-06-24 |
Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner |
42,087 | $0 | 42,087 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 7:16 pm |
2023-06-08 2032-06-24 |
Edgewise Therapeutics Inc. | EWTX | ROOT JONATHAN D Director |
42,087 | $0 | 42,087 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 7:16 pm |
2023-06-08 2032-06-24 |
Edgewise Therapeutics Inc. | EWTX | Edris Badreddin Director |
42,087 | $0 | 42,087 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 7:16 pm |
2023-06-08 2032-06-24 |
Edgewise Therapeutics Inc. | EWTX | Brege Laura Director |
42,087 | $0 | 42,087 (Direct) |
View |
| 2022-06-16 Exercise |
2022-06-21 6:50 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
67,927 | $0 | 607,580 (Direct) |
View |
| 2022-06-16 Exercise |
2022-06-21 6:50 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
54,419 | $1.93 | 607,580 (Direct) |
View |
| 2022-06-21 Exercise |
2022-06-21 6:50 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
13,508 | $0.71 | 607,580 (Direct) |
View |
| 2022-06-13 Exercise |
2022-06-15 6:39 pm |
N/A 2030-09-01 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
26,381 | $0 | 644,324 (Direct) |
View |
| 2022-06-15 Exercise |
2022-06-15 6:39 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
585 | $1.93 | 644,324 (Direct) |
View |
| 2022-06-13 Exercise |
2022-06-15 6:39 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
25,796 | $0.71 | 644,324 (Direct) |
View |
| 2022-06-08 Exercise |
2022-06-10 6:34 pm |
N/A 2030-09-01 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
27,306 | $0 | 507,463 (Direct) |
View |
| 2022-06-08 Exercise |
2022-06-10 6:34 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
27,306 | $0.71 | 507,463 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-07 7:03 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
47,287 | $0 | 797,815 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-07 7:03 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
30,137 | $1.93 | 797,815 (Direct) |
View |
| 2022-06-07 Exercise |
2022-06-07 7:03 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
17,150 | $0.71 | 797,815 (Direct) |
View |
| 2022-05-23 Exercise |
2022-05-25 6:11 pm |
N/A 2030-09-01 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
9,000 | $0.71 | 219,122 (Direct) |
View |
| 2022-05-01 Option Award |
2022-05-03 4:14 pm |
N/A 2025-05-01 |
Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer |
15,625 | $0 | 15,625 (Direct) |
View |
| 2022-05-01 Option Award |
2022-05-03 4:14 pm |
N/A 2025-05-01 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
15,625 | $0 | 15,625 (Direct) |
View |
| 2022-05-01 Option Award |
2022-05-03 4:14 pm |
N/A 2025-05-01 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
15,625 | $0 | 15,625 (Direct) |
View |
| 2022-05-01 Option Award |
2022-05-03 4:14 pm |
N/A 2025-05-01 |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
15,625 | $0 | 15,625 (Direct) |
View |
| 2022-05-01 Option Award |
2022-05-03 4:14 pm |
N/A 2025-05-01 |
Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO |
31,250 | $0 | 31,250 (Direct) |
View |
| 2022-05-01 Option Award |
2022-05-03 4:14 pm |
N/A 2025-05-01 |
Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO |
31,250 | $0 | 31,250 (Direct) |
View |
| 2022-02-25 Other |
2022-02-28 8:04 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | ROOT JONATHAN D Director |
3,473,543 | $0 | 3,489,168 (Indirect) |
View |
| 2022-01-21 Exercise |
2022-01-25 6:50 pm |
N/A 2030-09-01 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
5,400 | $0 | 217,684 (Direct) |
View |
| 2022-01-21 Exercise |
2022-01-25 6:50 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
5,400 | $0.71 | 217,684 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 5:51 pm |
N/A 2030-09-01 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
5,400 | $0 | 217,684 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 5:51 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
5,400 | $0.71 | 217,684 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-01 6:20 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
147,585 | $0.18 | 302,937 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-01 6:20 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
25,000 | $0.45 | 302,937 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-01 6:20 pm |
N/A 2027-08-08 |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
172,585 | $0 | 302,937 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-19 5:10 pm |
N/A 2031-08-17 |
Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-19 5:09 pm |
N/A 2031-08-17 |
Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-19 5:09 pm |
N/A 2031-08-17 |
Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO |
160,000 | $0 | 160,000 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-19 5:09 pm |
N/A 2031-08-17 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
140,000 | $0 | 140,000 (Direct) |
View |